Medicine guide
Picato
·
- Prescription status not stated
- Skin
- Active substance
- Ingenol mebutate
- Used in
- Skin
- Made by
- LEO Laboratories Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Picato is indicated for the cutaneous treatment of non?hyperkeratotic, non?hypertrophic actinic keratosis in adults.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | LEO Laboratories Ltd. |
|---|---|
| Active substance | Ingenol mebutate |
| Used in | Skin |
| Classification | D06BX02 · Skin |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2012-11-15 |
| Last updated by the regulator | 2020-07-31 |
| EMA product number | EMEA/H/C/002275 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).